Ovarian Cancer Incidence Corrected for Oophorectomy
AbstractCurrent reported incidence rates for ovarian cancer may significantly underestimate the true rate because of the inclusion of women in the calculations who are not at risk for ovarian cancer due to prior benign salpingo-oophorectomy (SO). We have considered prior SO to more realistically estimate risk for ovarian cancer. Kentucky Health Claims Data, International Classification of Disease 9 (ICD-9) codes, Current Procedure Terminology (CPT) codes, and Kentucky Behavioral Risk Factor Surveillance System (BRFSS) Data were used to identify women who have undergone SO in Kentucky, and these women were removed from the at-risk pool in order to re-assess incidence rates to more accurately represent ovarian cancer risk. The protective effect of SO on the population was determined on an annual basis for ages 5–80+ using data from the years 2009–2013. The corrected age-adjusted rates of ovarian cancer that considered SO ranged from 33% to 67% higher than age-adjusted rates from the standard population. Correction of incidence rates for ovarian cancer by accounting for women with prior SO gives a better understanding of risk for this disease faced by women. The rates of ovarian cancer were substantially higher when SO was taken into consideration than estimates from the standard population. View Full-Text
- Supplementary File 1:
DOCX-Document (DOCX, 44 KB)
Share & Cite This Article
Baldwin, L.A.; Chen, Q.; Tucker, T.C.; White, C.G.; Ore, R.N.; Huang, B. Ovarian Cancer Incidence Corrected for Oophorectomy. Diagnostics 2017, 7, 19.
Baldwin LA, Chen Q, Tucker TC, White CG, Ore RN, Huang B. Ovarian Cancer Incidence Corrected for Oophorectomy. Diagnostics. 2017; 7(2):19.Chicago/Turabian Style
Baldwin, Lauren A.; Chen, Quan; Tucker, Thomas C.; White, Connie G.; Ore, Robert N.; Huang, Bin. 2017. "Ovarian Cancer Incidence Corrected for Oophorectomy." Diagnostics 7, no. 2: 19.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.